Mechanistic studies on the activation of the SRC/FAK/RHO/ROCK signaling axis by FUS::DDIT3 to promote MLS metastasis provide a theoretical basis for its therapeutic strategy (Figure 4). The gene discussed is DDIT3; the disease is McLeod neuroacanthocytosis syndrome.